International Journal of Diabetes & Clinical Diagnosis Volume 3 (2016), Article ID 3:IJDCD-121, 3 pages
http://dx.doi.org/10.15344/2394-1499/2016/121
http://dx.doi.org/10.15344/2394-1499/2016/121
Short Communication
Effects of Combination Therapy with Liraglutide and Insulin Glargine as the Initial Treatment for Hyperglycemic Patients with Type 2 Diabetes: An Observational Study
References
- Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res ClinPract 28:103-117. View
- Vora J (2013) Combining incretin-based therapies with insulin: realizing the potential in type 2 diabetes. Diabetes Care 36 Suppl 2: S226-232. View
- Balena R, Hensley IE, Miller S, Barnett AH (2013) Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature. Diabetes Obes Metab 15: 485-502. View
- Holst JJ, Vilsbøll T (2013) Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings. Diabetes Obes Metab 15: 3-14. View
- Eng C, Kramer CK, Zinman B, Retnakaran R (2014) Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet 384: 2228-2234. View
- Lane W, Weinrib S, Rappaport J (2011) The effect of liraglutide added to U-500 insulin in patients with type 2 diabetes and high insulin requirements. Diabetes Technol Ther 13: 592-595. View
- Li CJ, Li J, Zhang QM, Lv L, Chen R, et al. (2012) Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity. Cardiovasc Diabetol 11: 142. View
- Ahmann A, Rodbard HW, Rosenstock J, Lahtela JT, de Loredo L, et al. (2015) Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-controlled trial. Diabetes ObesMetab 17: 1056-1064. View